PDCD1LG2 and uterine corpus sarcoma: To our knowledge, this is the first paper to describe the presence of PD-L1 and PD-L2 in endometrial cancer as such, and we are not aware that any of the currently described molecules have been described in uterine sarcoma so far, except for possibly IDO [31], galectin-1 [32] and galectin-3 [32–34].